| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |